Venture Round - Aurion Biotechnologies

Venture Round - Aurion Biotechnologies

Investment Firm

Overview

Aurion Biotechnologies is a clinical-stage biotech company.

Announced Date

Apr 12, 2022

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Deerfield

Deerfield

Deerfield is a debt and early_stage_venture firm.

Participant Investors

3

Investor Name
Participant InvestorVisionary Venture Fund
Participant InvestorAlcon
Participant InvestorDeerfield

Round Details and Background

Aurion Biotechnologies raised $120000000 on 2022-04-12 in Venture Round

Aurion Biotechnologies is a clinical-stage biotech company.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 12, 2022
Venture Round - Aurion Biotechnologies
6-120.0M

Recent Activity

There is no recent news or activity for this profile.